Endocrinology Articles & Analysis
22 news found
“Apart from diabetes and hypertension management, there are currently very limited treatment options to slow kidney disease progression in people with chronic kidney disease and type 1 diabetes,” said Janet McGill, Professor of Medicine in the Division of Endocrinology, Metabolism and Lipid Research at Washington University, and Co-chair of the study’s Executive ...
ByBayer AG
His background spans a number of therapeutic categories including psychiatry, infectious disease, endocrinology, oncology and allergy. As co-founder and chief development officer of Park Therapeutics, Dr. ...
(NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on rare endocrine disorders, announced that the Company will host two key opinion leaders in the field of pediatric endocrinology for a discussion of interim data from our Phase 2 OraGrowtH210 and PK/PD OraGrowtH212 Trials evaluating oral LUM-201 in Pediatric Growth Hormone Deficiency (PGHD). ...
An article presenting analyses of Continuous Glucose Monitoring (CGM) data from the randomised, placebo-controlled Phase 2b trial DIAGNODE-2 that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd®, has been published in the peer-reviewed scientific journal The Journal of Clinical Endocrinology & Metabolism (JCEM). As communicated on 23 ...
("Creative Medical Technology" or the "Company") (NASDAQ: CELZ), a leading biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, today announced the peer reviewed publication of positive, two-year follow-up data for the Company's StemSpine® study, showing significant efficacy of the StemSpine® ...
Preliminary (5 months) data on safety and endogenous insulin production have been published in the scientific journal Frontiers in Endocrinology. Updated 12-month results presented today at EASD The updated results provide additional support for a positive immunological and metabolic response in LADA patients with HLA DR3-DQ2. ...
Carl Malchoff, Professor Emeritus, Medicine/Endocrinology, Founder of the Endocrine Neoplasia Program at UConn Health, and a co-author of the manuscript, “The addition of pairwise microRNA expression profiling represents a clinically important development in precision molecular diagnosis of indeterminate thyroid nodules. ...
Carl Malchoff, Professor Emeritus, Medicine/Endocrinology, Founder of the Endocrine Neoplasia Program at UConn Health, and a co-author of the manuscript, “The addition of pairwise microRNA expression profiling represents a clinically important development in precision molecular diagnosis of indeterminate thyroid nodules. ...
An article presenting the 5-month interim results from the open-label trial GADinLADA that assessed three intralymphatic injections of the therapeutic diabetes vaccine Diamyd®, has been published in the peer-reviewed scientific journal Frontiers in Endocrinology. As communicated on December 7, 2021, immunological analyses after 5-months showed that the treatment with ...
The results of the research study have received academic recognition, are currently in pre-print for several journals and were presented as part of the European Congress of Endocrinology,. The project findings will serve as a valuable tool for patient advocacy groups and respective stakeholders in drawing the government's attention to the needs of Type 1 Diabetes patients in ...
Michael Crutchlow joins Kallyope after 15 years at Merck, where he most recently served as Executive Director, Late-Stage Clinical Research – Diabetes, Endocrinology and Metabolism following positions in clinical pharmacology, experimental therapeutics and early clinical biologics development. ...
“I look forward evaluating the use of LUM-201 for patients with NAFLD," said Laura Dichtel, MD, Assistant Professor, Harvard Medical School, Department of Endocrinology, Neuroendocrine Unit. "Prior studies have demonstrated growth hormone’s potential to treat NAFLD, given the hormone’s lipolytic actions in addition to its role as an anti-inflammatory cytokine. ...
He serves as a reviewer for many journals including Diabetes, Pediatric Diabetes, and the Journal of Clinical Endocrinology and Metabolism. “My laboratory is very excited to collaborate with Dr. ...
“In this publication, we are beginning to get a picture of the long-term safety, tolerability, and metabolic benefits from the Revita procedure in patients who are poorly controlled on oral antidiabetic agents,” said David Hopkins, FRCP, Director of the Diabetes Endocrinology and Obesity Institute and Network, King’s Health Partners, London. ...
If ongoing studies are successful, it represents a potentially exciting treatment option to help achieve glycemic control in patients for whom the alternative would otherwise be insulin intensification,” said Vivian Fonseca, M.D., Chief of Endocrinology, Professor of Medicine and Pharmacology and Assistant Dean for Clinical Research at Tulane University. ...
Today’s news is the latest in a series of milestones achieved during 2021, including a meeting with the FDA (INTERACT) earlier this month regarding IsletRx, receipt of a patent for the IsletRx technology from Japan, and the publishing of a scientific paper detailing the IsletRx program in the prestigious Frontiers in Endocrinology peer reviewed scientific journal. "We are ...
This was quickly followed by a move to Endocrinology for 9 years as a senior research officer where numerous immunoassays were developed to determine the physiological functions of a number of hormones and neurotransmitters. ...
Tissue Genesis, LLC, the leading provider of cell isolation technology is pleased to announce that the Icellator® is being used to generate therapeutic cell preparations at the V.P. Komisarenko Institute of Endocrinology and Metabolism in Kiev, Ukraine, for patients with critical limb ischemia (CLI). ...
He is qualified as a professor of medicine at Heidelberg University, Germany, and he teaches internal medicine and endocrinology at the university. Anna Lisa Jenkins, MBBS, FCRP Dr. Jenkins, MBBS, FRCP is currently the Chief Executive Officer of PlaqueTec. ...
Thomas Zoeller, an expert in developmental endocrinology and endocrine-disruptors, and D. Joseph Jerry, an expert on the intersection of hormones and genetics, both at UMass Amherst. ...